Eli Lilly Receives FDA Approval to Expand Zepbound Label
Eli Lilly Receives FDA Approval to Expand Zepbound Label is drawing significant interest across the industry.
Eli Lilly said Monday that the US Food and Drug Administration has approved a label expansion for weight-management drug Zepbound to include a four-dose single-patient use of KwikPen. The company...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Terms of Trade: Is Tamil Nadu really richer than Bihar?
- Price drop alert: 10 Fossil watches with a flat 30% off; grab deals before they are gone
- Number of homes being built falls by 6.5pc in the last quarter of 2025, CSO shows
- Chhatra League posters appear on DU campus, Ducsu leaders issue ultimatum
Source: Original →